Wave Life Sciences Newsroom

Wave Life Sciences' WVE-007: A Promising New Player in Obesity Treatment

TipRanksDec 25 06:55 ET

Wave Life Sciences (WVE) Gets a Buy From Truist Financial

TipRanksDec 24 07:15 ET · Ratings

Express News | Wave Life Sciences Ltd - Expects First-in-Human Study of Wve-007 in Q1 2025

ReutersDec 23 08:31 ET

Wave Life Sciences Announces Submission of First Clinical Trial Application for WVE-007 (SiRNA Targeting INHBE) in Obesity

GlobeNewswireDec 23 08:30 ET

Express News | Wave Life Sciences Announces Submission of First Clinical Trial Application for Wve-007 (Sirna Targeting Inhbe) in Obesity

ReutersDec 23 08:30 ET

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 09:56 ET

Buy Rating for Wave Life Sciences: Favorable Regulatory Environment and Promising WVE-003 Data

TipRanksDec 11 23:55 ET · Ratings

Wave Life Sciences: Positioned for Growth With Promising Huntington's Treatment and Strategic Advantages

TipRanksDec 5 12:08 ET

Insider Sale: President and CEO of $WVE (WVE) Sells 50,000 Shares

Quiver QuantitativeNov 27 21:15 ET

Wave Life Sciences CEO Paul Bolno Sells $750,000 in Shares

Investing.com Nov 27 21:02 ET

Truist Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating

Moomoo NewsNov 27 07:33 ET · Ratings

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswireNov 26 08:30 ET

In 2025, US Biotech stocks are expected to rise significantly. jpmorgan's top pick is vertex pharmaceuticals (VRTX.US).

Vertex pharmaceuticals (Vertex) ranked first on the list of US biotechnology stock selections for 2025 released by jpmorgan.

Zhitong FinanceNov 26 02:22 ET

Vertex Leads J.P. Morgan's Top Biotech Picks List for 2025

Seeking AlphaNov 25 15:10 ET

Wave Life Sciences Is Maintained at Outperform by Mizuho

Dow JonesNov 21 08:26 ET · Ratings

Mizuho Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Announces Target Price $22

Moomoo NewsNov 21 07:31 ET · Ratings

Express News | Wave Life Sciences Ltd : Mizuho Raises Target Price to $22 From $19

ReutersNov 21 06:50 ET

Earnings Update: Here's Why Analysts Just Lifted Their Wave Life Sciences Ltd. (NASDAQ:WVE) Price Target To US$22.20

Simply Wall StNov 15 07:43 ET

Wave Life Sciences Third Quarter 2024 Earnings: Misses Expectations

Yahoo FinanceNov 14 07:27 ET

B.Riley Financial Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $22

Moomoo NewsNov 13 21:32 ET · Ratings